Jukka Kallio

557 citations
20 papers · 425 indexed · h-index 11
Topics
Bladder and Urothelial Cancer Treatments (6 papers)Renal cell carcinoma treatment (5 papers)Urinary and Genital Oncology Studies (3 papers)
Partner nations
FinlandSwedenSlovakia

In The Last Decade

Jukka Kallio

20 papers receiving 411 citations

Peers

Jukka Kallio
Comparison fields: 5 of 61
  • Surgery 243
  • Molecular Biology 138
  • Oncology 102
  • Pulmonary and Respiratory Medicine 79
  • Urology 74
Replace Mona Fahmy with:
Mona Fahmy Canada
M. Takashi Japan
Antonio Curotto Italy
Sayuri Onishi Japan
Sean Ong Australia
Kim E.M. van Kessel Netherlands
Akio Emoto Japan
Jin‐Bei Huang China
T.J. Crook United Kingdom
A. Brisuda Czechia
Jukka Kallio relative to Mona Fahmy Canada Mona Fahmy's profile →
Citations per field
00.5×3.3×
Mona Fahmy · 1×
Citations per year

Countries citing papers authored by Jukka Kallio

Since Specialization
Citations

This map shows the geographic impact of Jukka Kallio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jukka Kallio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jukka Kallio more than expected).

Fields of papers citing papers by Jukka Kallio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jukka Kallio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jukka Kallio. The network helps show where Jukka Kallio may publish in the future.

Co-authorship network of co-authors of Jukka Kallio

This figure shows the co-authorship network connecting the top 25 collaborators of Jukka Kallio. A scholar is included among the top collaborators of Jukka Kallio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jukka Kallio. Jukka Kallio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 10
2 11
3 10
4 28
5 17
6 3
7 7
8 16
9 34
10 1
11 9
12 21
13 4
14 30
15 2
16 169
17
Soluble immunological parameters and early prognosis of renal cell cancer patients.
23
18 1
19 26
20 3

About Jukka Kallio

Jukka Kallio is a scholar working on Urology, Biochemistry and Cancer Research, having authored 20 papers that have together received 425 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (6 papers), Renal cell carcinoma treatment (5 papers) and Urinary and Genital Oncology Studies (3 papers). The work is most often cited by research in Urology (74 citations), Surgery (243 citations) and Oncology (102 citations). Jukka Kallio has collaborated with scholars based in Finland, Sweden and Slovakia. Frequent co-authors include Teuvo L.J. Tammela, Erkki Rintala, Pertti Rajala, Mika Raitanen, Risto Aine, Harri Juusela, Pirkko Kellokumpu‐Lehtinen, Pasi Hirvikoski, H Helin and Tiina Luukkaala. Their work appears in journals such as The Journal of Urology, British Journal of Cancer and European Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026